...
首页> 外文期刊>Stem cells international >Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition
【24h】

Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition

机译:通过CRISPR干扰增强MIR-199A / 214集群的抑制因缺氧条件下人类诱导多能干细胞衍生神经干细胞的肿瘤热衷

获取原文
获取原文并翻译 | 示例

摘要

The human induced pluripotent stem cell (hiPSC) provides a breakthrough approach that helps overcoming ethical and allergenic challenges posed in application of neural stem cells (NSCs) in targeted cancer gene therapy. However, the tumor-tropic capacity of hiPSC-derived NSCs (hiPS-NSCs) still has much room to improve. Here we attempted to promote the tumor tropism of hiPS-NSCs by manipulating the activity of endogenous miR-199a/214 cluster that is involved in regulation of hypoxia-stimulated cell migration. We first developed a baculovirus-delivered CRISPR interference (CRISPRi) system that sterically blocked the E-box element in the promoter of the miR-199a/214 cluster with an RNA-guided catalytically dead Cas9 (dCas9). We then applied this CRISPRi system to hiPS-NSCs and successfully suppressed the expression of miR-199a-5p, miR-199a-3p, and miR-214 in the microRNA gene cluster. Meanwhile, the expression levels of their targets related to regulation of hypoxia-stimulated cell migration, such as HIF1A, MET, and MAPK1, were upregulated. Further migration assays demonstrated that the targeted inhibition of the miR-199a/214 cluster significantly enhanced the tumor tropism of hiPS-NSCs both in vitro and in vivo. These findings suggest a novel application of CRISPRi in NSC-based tumor-targeted gene therapy.
机译:人诱导的多能干细胞(HIPSC)提供了一种突破性方法,有助于克服在靶向癌症基因治疗中克服神经干细胞(NSC)的伦理和过敏性挑战。然而,HIPSC衍生的NSCs(HIPS-NSCs)的肿瘤 - 热带容量仍然有很多改进空间。在这里,我们试图通过操纵缺氧刺激细胞迁移调节的内源性miR-199A / 214簇的活性来促进髋关节患者的肿瘤热衷。我们首先开发了一种杆状病毒提供的CRISPRUPS干扰(CRISPRI)系统,即在MIR-199A / 214簇的启动子与RNA引导的催化死CAS9(DCAS9)的启动子中的E-BOX元件。然后,我们将这种CRISPRI系统应用于HIPS-NSCs,并成功地抑制了MIR-199A-5P,MIR-199A-3P和MIR-214的表达式MICRRNA基因集群。同时,上调了与调节缺氧刺激细胞迁移的靶标的靶标的表达水平,例如HIF1a,满足和MAPK1。进一步的迁移测定证明,MiR-199A / 214簇的靶向抑制显着增强了体外和体内髋关节的肿瘤热带。这些发现表明了基于NSC的肿瘤靶向基因治疗中的CRIPRI的新型应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号